Page last updated: 2024-11-08

isoflurophate and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

isoflurophate has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Isoflurophate: A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ATHENS, JW1
RAAB, SO1
HAAB, OP1
BOGGS, DR1
ASHENBRUCKER, H1
CARTWRIGHT, GE1
WINTROBE, MM1

Other Studies

1 other study available for isoflurophate and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
LEUKOKINETIC STUDIES. X. BLOOD GRANULOCYTE KINETICS IN CHRONIC MYELOCYTIC LEUKEMIA.
    The Journal of clinical investigation, 1965, Volume: 44

    Topics: Bone Marrow Cells; Bone Marrow Transplantation; Busulfan; Cell Division; Colchicine; Granulocytes; H

1965